StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4] by Year

Specialty Surgery [reported separately through FY2019Q4] — Worldwide operational (constant-currency) growth YoY (%) (%)

Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4]: -29.0% in FY2019, down 29.4 pts from a year earlier. No newer figure appears in the documents we track.

Latest, FY2019
-29.0%
Period ended Dec 29, 2019
Change on a year earlier
-29.4 pts
0.4% in FY2018
History
3 years
Since FY2017
Sources
3
Documents cited below

Where the FY2019 figure comes from

“|| WW | 926 | 1,342 | (31.0 | ) | (29.0 | ) | (2.0 | )”

Source: Form 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecialty Surgery [reported separately through FY2019Q4] — Worldwide operational (constant-currency) growth YoY (%) (%)Year on yearSource
FY2019Dec 29, 2019-29.0%-29.4 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
FY2018Dec 30, 20180.4%+6.2 ptsForm 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
FY2017Dec 31, 2017-5.8%–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Breakdown

What makes up specialty Surgery [reported separately through FY2019Q4]

Cite this data

StockData. (2026). Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4] (%), annual FY2017–FY2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt-surg-specialty-ops-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.